Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study.
Sanmartín Fernández M, Anguita Sánchez M, Arribas F, Barón-Esquivias G, Barrios V, Cosin-Sales J, Esteve-Pastor MA, Freixa-Pamias R, Lekuona I, Pérez-Cabeza AI, Ureña I, Vázquez Rodríguez JM, Rafols Priu C, Marin F. Sanmartín Fernández M, et al. Among authors: baron esquivias g. Cardiol J. 2022;29(4):601-609. doi: 10.5603/CJ.a2022.0044. Epub 2022 May 27. Cardiol J. 2022. PMID: 35621092 Free PMC article.
Quality of life, adherence and satisfaction of patients with auricular fibrillation treated with dabigatran or vitamin K antagonists.
Barrios V, Escobar C, Barón Esquivias G, Gómez Doblas JJ, Recalde Del Vigo E, Segura Martínez L, Alvarez Garcia P, Alonso Valladares F, Toril Lopez J, Chopo Alcubilla JM. Barrios V, et al. Rev Clin Esp (Barc). 2019 Aug-Sep;219(6):285-292. doi: 10.1016/j.rce.2018.12.006. Epub 2019 Mar 17. Rev Clin Esp (Barc). 2019. PMID: 30894251 English, Spanish.
Use of edoxaban in clinical practice: Comparison of data from the Spanish population in the ETNA-AF-Europe registry.
Barón-Esquivias G, Roldán Rabadán I, García Quintana A, Cerezo Manchado JJ, Antorrena Miranda I, Gómez-Barrado JJ, Pérez Paredes M, Santas E, Pindado Rodríguez J, Muñoz-Robles JA, Oliver-Miñarro D, Santamaría A; investigators of ETNA AF Spain. Barón-Esquivias G, et al. Future Cardiol. 2020 Sep;16(5):469-480. doi: 10.2217/fca-2020-0024. Epub 2020 Mar 31. Future Cardiol. 2020. PMID: 32228182
Gender differences in antithrombotic treatment in patients with atrial fibrillation from Spain versus the rest of Western Europe. GLORIA-AF Program.
López-Sendón JL, Alonso-Rodríguez D, Barón-Esquivias G, Cosin-Sales J, Marín F, Galera-Llorca J, Jiménez N, Marler S, Huisman MV, Lip GYH; Spanish GLORIA-AF investigators. López-Sendón JL, et al. Med Clin (Barc). 2022 Aug 26;159(4):177-182. doi: 10.1016/j.medcli.2021.09.016. Epub 2021 Dec 8. Med Clin (Barc). 2022. PMID: 34895750 Free article. English, Spanish.
Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study.
López-Gálvez R, Rivera-Caravaca JM, Anguita Sánchez M, Sanmartín Fernández M, Rafols C, Pérez-Cabeza AI, Barón Esquivias G, Lekuona Goya I, Vázquez Rodríguez JM, Cosín Sales J, Arribas Ynsaurriaga F, Barrios V, Freixa-Pamias R, Marín F. López-Gálvez R, et al. Among authors: baron esquivias g. Eur J Clin Invest. 2022 Sep;52(9):e13788. doi: 10.1111/eci.13788. Epub 2022 Apr 14. Eur J Clin Invest. 2022. PMID: 35395094
96 results